Cubist Systematic Strategies’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,197
| Closed | -$1.32M | – | 3767 |
|
|
2024
Q1 | $1.32M | Buy |
18,197
+2,615
| +17% | +$175K | 0.01% | 1943 |
|
|
2023
Q4 | $954K | Sell |
15,582
-18,000
| -54% | -$1.07M | 0.01% | 2095 |
|
|
2023
Q3 | $1.92M | Buy |
+33,582
| New | +$2.03M | 0.01% | 1397 |
|
|
2023
Q1 | – | Sell |
-36,225
| Closed | -$2.27M | – | 4291 |
|
|
2022
Q4 | $2.27M | Buy |
36,225
+2,052
| +6% | +$118K | 0.01% | 1747 |
|
|
2022
Q3 | $1.7M | Sell |
34,173
-3,317
| -9% | -$184K | 0.01% | 2167 |
|
|
2022
Q2 | $2.2M | Sell |
37,490
-65,704
| -64% | -$3.62M | 0.01% | 1763 |
|
|
2022
Q1 | $5.46M | Buy |
103,194
+45,674
| +79% | +$2.64M | 0.05% | 658 |
|
|
2021
Q4 | $3.49M | Buy |
57,520
+28,127
| +96% | +$1.67M | 0.03% | 907 |
|
|
2021
Q3 | $1.65M | Buy |
+29,393
| New | +$1.61M | 0.02% | 1163 |
|
|
2021
Q2 | – | Sell |
-38,967
| Closed | -$1.72M | – | 3049 |
|
|
2021
Q1 | $1.72M | Sell |
38,967
-31,086
| -44% | -$1.31M | 0.02% | 1146 |
|
|
2020
Q4 | $2.44M | Buy |
70,053
+53,985
| +336% | +$1.92M | 0.03% | 827 |
|
|
2020
Q3 | $585K | Sell |
16,068
-67,356
| -81% | -$2.5M | 0.01% | 1658 |
|
|
2020
Q2 | $3.13M | Buy |
83,424
+62,841
| +305% | +$2.51M | 0.05% | 553 |
|
|
2020
Q1 | $755K | Buy |
20,583
+6,081
| +42% | +$236K | 0.02% | 1006 |
|
|
2019
Q4 | $587K | Sell |
14,502
-36,379
| -71% | -$1.36M | 0.01% | 1452 |
|
|
2019
Q3 | $1.76M | Buy |
50,881
+10,423
| +26% | +$343K | 0.04% | 680 |
|
|
2019
Q2 | $1.28M | Buy |
40,458
+17,777
| +78% | +$528K | 0.02% | 897 |
|
|
2019
Q1 | $678K | Buy |
22,681
+5,639
| +33% | +$162K | 0.02% | 988 |
|
|
2018
Q4 | $526K | Buy |
17,042
+10,242
| +151% | +$374K | 0.02% | 932 |
|
|
2018
Q3 | $258K | Buy |
+6,800
| New | +$257K | 0.01% | 1266 |
|
|
2018
Q2 | – | Sell |
-6,388
| Closed | -$215K | – | 1982 |
|
|
2018
Q1 | $215K | Sell |
6,388
-29,006
| -82% | -$1.11M | 0.01% | 1356 |
|
|
2017
Q4 | $1.57M | Buy |
35,394
+29,110
| +463% | +$1.33M | 0.08% | 314 |
|
|
2017
Q3 | $315K | Sell |
6,284
-15,154
| -71% | -$774K | 0.02% | 1123 |
|
|
2017
Q2 | $1.13M | Buy |
21,438
+12,924
| +152% | +$693K | 0.07% | 374 |
|
|
2017
Q1 | $473K | Buy |
+8,514
| New | +$470K | 0.03% | 665 |
|
|
2016
Q4 | – | Sell |
-3,673
| Closed | -$177K | – | 1842 |
|
|
2016
Q3 | $177K | Hold |
3,673
| – | – | 0.01% | 1307 |
|
|
2016
Q2 | $203K | Buy |
+3,673
| New | +$202K | 0.01% | 1328 |
|
|
2016
Q1 | – | Sell |
-8,424
| Closed | -$434K | – | 1773 |
|
|
2015
Q4 | $434K | Buy |
8,424
+3,721
| +79% | +$185K | 0.03% | 901 |
|
|
2015
Q3 | $212K | Buy |
+4,703
| New | +$222K | 0.01% | 1446 |
|
|
2015
Q2 | – | Sell |
-10,242
| Closed | -$439K | – | 1985 |
|
|
2015
Q1 | $439K | Buy |
+10,242
| New | +$390K | 0.02% | 1011 |
|
|
2014
Q4 | – | Sell |
-7,710
| Closed | -$250K | – | 2005 |
|
|
2014
Q3 | $250K | Sell |
7,710
-6,639
| -46% | -$222K | 0.02% | 1219 |
|
|
2014
Q2 | $486K | Buy |
+14,349
| New | +$460K | 0.03% | 750 |
|
Other funds holding PBH
AI
Cubist Systematic Strategies's PBH Position: Q2 2024 in Review
Cubist Systematic Strategies sold out of Prestige Consumer Healthcare (PBH) in Q2 2024, closing a stake of 18,197 shares — an estimated $1.32M sold.
Cubist Systematic Strategies first reported a position in PBH in Q2 2014 and held it in 32 quarters. The position peaked at $5.46M in Q1 2022. 306 funds tracked by Wall St. Rank hold PBH as of Q2 2024.
- Cubist Systematic Strategies reported no remaining Prestige Consumer Healthcare position as of Q2 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 18,197 Prestige Consumer Healthcare shares in Q2 2024, an estimated $1.32M.
- Cubist Systematic Strategies first reported a position in Prestige Consumer Healthcare in Q2 2014 and held it in 32 quarters.
- Cubist Systematic Strategies's Prestige Consumer Healthcare position peaked at $5.46M in Q1 2022.
- 306 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2024.
Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.